6/10/2009 | SS | Penwest shareholders Tang Capital, Perceptive win seats on board
|
6/2/2009 | SS | Penwest shareholders' partial slate of nominees backed by proxy firm
|
6/1/2009 | SS | Penwest nominees receive mixed support from proxy advisory firms
|
5/26/2009 | SS | Penwest investors seek faster resolution of lawsuit against company
|
5/19/2009 | SS | Penwest asks shareholders to reject dissident's slate on June 10
|
5/15/2009 | SS | Penwest Pharmaceuticals investors seek support for vote on June 10
|
4/22/2009 | SS | Penwest Pharmaceuticals' nomination a surprise to Tang, Perceptive
|
3/30/2009 | SS | Penwest investors seek to put wind-down of company to shareholder vote
|
3/16/2009 | SS | Penwest shareholders want to see company's books
|
3/12/2009 | SS | Penwest reiterates focus on business plan, adopts rights plan amid shareholder unrest
|
3/3/2009 | SS | Penwest investors ask company to wind down, preserve revenue stream
|
2/19/2009 | SS | Penwest Pharmaceuticals investor buys 665,000 shares
|
1/12/2009 | SS | Penwest Pharmaceuticals shareholders seek board representation
|
12/19/2008 | SS | Penwest Pharmaceuticals shareholder demands answers from company's board
|
11/21/2008 | SS | Penwest Pharmaceuticals' largest shareholder suggests it become a virtual company
|
10/23/2008 | SS | Perceptive Advisors reports 21.15% ownership interest in Penwest Pharmaceuticals
|
9/26/2008 | CVHY | Penwest Pharmaceuticals files $75 million shelf
|
7/18/2008 | SS | Perceptive Advisors reports 20.75% stake in Penwest
|
7/17/2008 | SS | Perceptive Advisors owns 20.75% of Penwest Pharmaceuticals
|
3/6/2008 | PP | New Issue: Penwest secures $25.09 million from private placement of stock, warrants
|
3/6/2008 | PP | Market Commentary: Energy Quest negotiates $120 million sale of debentures; Centenario plans C$58 million deal
|
8/29/2006 | BT | Market Commentary: Teva lower; Endo, Penwest up; StemCells gains 7%; Nastech higher; Hemispherx rises 11%
|
8/16/2006 | BT | Penwest sues Endo for Opana ER
|
7/26/2006 | BT | Penwest second-quarter revenue declines to $1.1 million
|
6/23/2006 | BT | Endo receives FDA approval for pain drug Opana; revises 2006 estimates
|
6/23/2006 | BT | Market Commentary: Neurocrine, DOV fall on Pfizer nixing indiplon funding; Endo rises 10%, Penwest gains 37%
|
3/2/2006 | BT | Penwest says 2005 revenue up $1.1 million to $6.2 million
|
2/10/2006 | BT | Penwest nalbuphine ER analgesic reduces pain during phase 2a study
|
12/20/2005 | BT | Penwest says phase 2a trial shows PW2132 in chronic heart failure patients more effective than Demadex
|
12/15/2005 | BT | Penwest says enrollment complete in phase 2a trial of PW4142 for pain
|
7/27/2005 | BTCV | Penwest Pharmaceuticals files $75 million shelf
|
12/10/2004 | PP | New Issue: Penwest Pharmaceuticals raises $35 million in private placement
|
12/10/2004 | PP | Market Commentary: Private placement volume stalls on lower oil, stocks; Penwest raises $35 million
|